Skip to content

Medical-device intelligence

JJX: Single (Specified) Analyte Controls (Assayed And Unassayed)

FDA product code JJX: Single (Specified) Analyte Controls (Assayed And Unassayed). View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
JJX
FDA device name
Single (Specified) Analyte Controls (Assayed And Unassayed)
Device class
1
Regulation number
862.1660
Medical specialty
Clinical Chemistry
Review panel
CH

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore clinical chemistry records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

493 clearance records and 42 recall records in the covered releases, across 154 source company names and 1 product codes. Dated history runs from Oct 29, 1976 to Apr 24, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
JJX · Single (Specified) Analyte Controls (Assayed And Unassayed)49342

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

535 matching records
Device / recordCompany in FDA recordSourceSource date
OXICOM CONTROLK053327 · JJXBionostics, Inc.510(k)Jan 26, 2006FDA decision date
ARCHITECT DHEA-S CALIBRATORS (A-F) AND CONTROLS (LOW, MEDIUM AND HIGH)K060027 · JJXBiokit, S.A.510(k)Jan 26, 2006FDA decision date
LIBERTY GLUCOSE CONTROL, MODEL 2120031K052980 · JJXLiberty Healthcare Group, Inc.510(k)Nov 30, 2005FDA decision date
ROCHE DIAGNOSTICS ELECSYS PROLACTIN II CALCHECKK053059 · JJXRoche Diagnostics510(k)Nov 28, 2005FDA decision date
CLINIQA LIQUID QC BILIRUBIN CONTROLS LEVELS 1, 2 & 3; CLINIQA LINICAL BILIRUBIN CALIBRATION VERIFIERS LEVELS A-EK052679 · JJXCliniqa Corporation510(k)Nov 18, 2005FDA decision date
HBA1C LINEARITY SETK052010 · JJXCone Bioproducts510(k)Oct 4, 2005FDA decision date
IRMA TRUPOINT CREATININE CONTROL KITK050983 · JJXInternational Technidyne Corporation510(k)May 16, 2005FDA decision date
RNA1C CONTROL FOR NYCOCARD HBA1CK050961 · JJXBionostics, Inc.510(k)May 13, 2005FDA decision date
PREGNANCY-SKREENK050328 · JJXBiochemical Diagnostic, Inc.510(k)Mar 29, 2005FDA decision date
RNA1C HEMOGLOBIN A1C CONTROL FOR BAYER DCA2000 AND DCA2000+ ANALYZERK050100 · JJXBionostics, Inc.510(k)Feb 25, 2005FDA decision date
LIQUICHEK BNP CONTROLK043584 · JJXBio-Rad Laboratories, Inc.510(k)Feb 8, 2005FDA decision date
MODIFICATION TO ROCHE ELECSYS FOLATE II CALCHECK IIK043320 · JJXRoche Diagnostics Corp.510(k)Dec 17, 2004FDA decision date
LIQUID STABLE HBA1C CONTROLK043070 · JJXCanterbury Scientific , Ltd.510(k)Dec 9, 2004FDA decision date
MAS, DADE AND LIQUID ASSAYED DIABETES CONTROLK042717 · JJXMedical Analysis Systems, Inc.510(k)Nov 5, 2004FDA decision date
LIQUICHEK ELEVATED CRP CONTROLK042837 · JJXBio-Rad510(k)Nov 2, 2004FDA decision date
DIAZYME HOMOCYSTEINE ENZYMATIC ASSAY KITK042448 · JJXGeneral Atomics510(k)Oct 29, 2004FDA decision date
VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-HBS CONTROLSK042303 · JJXOrtho-Clinical Diagnostics510(k)Sep 27, 2004FDA decision date
TRACKEASE SMART SYSTEM BLOOD GLUCOSE SYSTEMK042080 · JJXHome Diagnostics, Inc.510(k)Aug 19, 2004FDA decision date
ABBOTT IMMUNOASSAY/CLINICAL CHEMISTRY SINGLE ANALYTE QUALITY CONTROL MATERIALS (ASSAYED) AND ABBOTT ESTRADIOL CALIBRATORK041687 · JJXAbbott Laboratories510(k)Aug 18, 2004FDA decision date
ABBOTT ARCHITECT STAT TROPONIN I LIQUID ASSAYED CARDIAC MARKER CONTROL LEVEL L, M AND HK041194 · JJXMedical Analysis Systems, Inc.510(k)Aug 16, 2004FDA decision date
INTERLAB MICROCAL SERUM CONTROLSK041871 · JJXTrouble Shooter Consuling, Inc.510(k)Aug 16, 2004FDA decision date
CLINIQA LIQUID QC TDM CONTROLS LEVELS 1,2 & 3/CLINIQA LINICAL TDM CALIBRATION VERIFIERS LEVELS A-E FOR OLYMPUS AU SYSTEMK041898 · JJXCliniqa Corporation510(k)Aug 16, 2004FDA decision date
WAKO LIPID CONTROL, LEVEL 1 AND LEVEL 2K040918 · JJXWako Chemicals USA, Inc.510(k)May 17, 2004FDA decision date
LINICAL PROTEIN 1 CALIBRATION VERIFIERS LEVELS A - E FOR OLYMPUS AU ANALYZERSK040927 · JJXCliniqa Corporation510(k)May 17, 2004FDA decision date
NOVA GLUCOSE LOW/HIGH LEVEL CONTROL SOLUTIONSK041016 · JJXNova Biomedical Corp.510(k)May 7, 2004FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗